TorreyPines Therapeutics
Records under this name other than patents TorreyPines Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to TorreyPines Therapeutics
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,244,739 | Compounds and uses thereof in modulating amyloid beta Formerly held Term ended Term ended Mar 21, 2025 · USPTO record | Term ended | Term ended Mar 21, 2025 | USPTO record |
| US 7,781,442 | Compounds and uses thereof in modulating amyloid beta Formerly held Term ended Term ended Nov 10, 2024 · USPTO record | Term ended | Term ended Nov 10, 2024 | USPTO record |
| US 7,645,588 | Composition Comprising a Cell Comprising a STIM1 Protein and an Agent That Modulates Intracellular Calcium and Methods of Use Formerly held Term ended Term ended Mar 29, 2024 · High confidence | Term ended | Term ended Mar 29, 2024 | High confidence |
| US 6,495,700 | Process for producing phenserine and its analog Term ended Term ended Jan 9, 2022 · USPTO record | Term ended | Term ended Jan 9, 2022 | USPTO record |
| US 7,799,808 | α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom Formerly held Lapsed on the fee record Ended Sep 21, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 21, 2018 | USPTO record |